
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is attractive because its core Zio franchise continues to deliver durable mid-teens growth while the business demonstrates strong operating leverage, with revenue of $221.6M up 14.9% y/y and adjusted EBITDA of $51.2M at a 23.1% margin, far above expectations. Even with elevated GAAP operating expenses of $197.0M, adjusted opex fell 2.0% y/y and gross margin expanded to 74.2%, showing the underlying model can scale efficiently as manufacturing automation, product mix, and operating discipline improve. Looking ahead, management’s framework for roughly $1.75B of combined 2027 revenue, above 70% gross margin, and at least 15% adjusted EBITDA margin supports the view that VitalConnect broadens the addressable market and strengthens the long-term growth path despite near-term integration noise.
Bears say
iRhythm Holdings is facing a deteriorating fundamental setup because 3Q26 revenue of $221.6M, up 14.9% y/y, still missed consensus while Zio AT was flat and new-account onboarding slowed as customers waited for the combined AT/VitalPatch platform. Management also pushed the Zio MCT FDA submission into 2027, undermining the near-term growth thesis and contributing to lowered organic expectations, with 2026 guidance only partly lifted by $16M of VitalConnect offsetting an $8.5M organic headwind. Beyond execution issues, the company remains burdened by FDA warning-letter scrutiny, 2024 compliance observations, an ongoing DOJ investigation tied to 2017-2022 reimbursement claims, reimbursement pressure, and rising competition, all of which can weigh on confidence and valuation.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About iRhythm Technologies (IRTC) Forecast
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares